Rapid results with objective data at the point of treatment.

Aiding clinicians’ understanding of adherence and the root cause of treatment failure.

Test Menu

*Available with CE Mark. Others in Development.

Assay Description RUO CE

Clozapine*

For the rapid measurement of active drug in blood for monitoring patient adherence to antipsychotic therapy.

Olanzapine

Total Aripiprazole

Quetiapine

Total Risperidone

CLZ-MCI

OLZ-MCI

PAL-MCI

QTP-MCI

ARI-MCI

RSP-MCI

CLZ-MCI-RUO

OLZ-MCI-RUO

PAL-MCI-RUO

QTP-MCI-RUO

ARI-MCI-RUO

RSP-MCI-RUO

Paliperidone

Psychiatric drug adherenceshouldn’t be a question.

1 | Place the RFID card 3 | Insert the cartridge 4 | Close the door - done!

4-step procedure

2 | Collect the sample

The MyCaretm Insite Analyser provides valuable point of care testing for today’s psychiatry.

The Insite measures the blood levels of the most common antipsychotic drugs. Similar to a blood glucose test, Insite requires only a drop of blood taken by finger-stick and generates results in approximately 7 minutes. Conducting the test requires minimal training.

ConnectivityResults are transferred via ethernet connection or secure wi-fi

Web portal or computer connection available (selectable by configuration)

Compatible with most EMR

Fast. Simple. Accurate.

@MyCareTests /SaladaxBiomedical+1 610 419-6731hello@saladax.comMyCareTests.com

© 2019 Saladax Biomedical, Inc. MyCare™ is registered trademark of Saladax Biomedical, Inc. 116 Research Drive, Bethlehem, PA 18015 USA Tel: +1 610 419-6731MyCareTests.com LIT PSY-005 Rev 03

Contact Us Today

FactsSize: 160 x 135 x 145 mm, weight: 2.2 kg

LCD color touch screen

No manual calibration required

Requires minimal training

Allows input of Patient ID and Operator ID

Optional barcode reader and printer

The analyser software can easily be upgraded to accommodate future tests